RIVERSIDE DOCTORS HOSPITAL WILLIAMSB
1. Target Overview & Investment Thesis
RIVERSIDE DOCTORS HOSPITAL WILLIAMSB is a 40-bed suburban community hospital in nan, VA with $74.0M in net patient revenue and a 15.9% operating margin. The hospital serves a payer mix of 45.2% Medicare, 2.8% Medicaid, and 52.0% commercial.
Thesis: Turnaround. Our ML models identify $5.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.9% to 23.3% (+736bps).
| Net Revenue HCRIS | $74.0M |
| Current EBITDA COMPUTED | $11.8M |
| Operating Margin COMPUTED | 15.9% |
| Occupancy HCRIS | 47.3% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 31.5% |
| Distress Probability ML | 48.2% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 15.9% places it above the state median. Among 41 size-comparable peers (20-80 beds), the median margin is 4.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-80), prioritizing same-state peers. 41 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIVERSIDE DOCTORS HOSPITAL WIL (Target) | VA | 40 | $74.0M | 15.9% |
| LONESOME PINE HOSPITAL | VA | 56 | $175.6M | 17.2% |
| CULPEPER MEMORIAL HOSPITAL | VA | 70 | $153.9M | 9.3% |
| COMMUNITY MEMORIAL HOSPITAL | VA | 66 | $135.2M | -31.0% |
| STAFFORD HOSPITAL | VA | 61 | $127.9M | 5.7% |
| SOUTHSIDE COMMUNITY HOSPITAL | VA | 80 | $113.4M | 7.3% |
| RIVERSIDE WALTER REED | VA | 67 | $108.2M | 12.5% |
| HALIFAX REGIONAL HOSPITAL | VA | 44 | $104.6M | -16.5% |
| SHORE MEMORIAL HOSPITAL | VA | 52 | $103.1M | 11.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $901K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $47K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $11.8M |
| + RCM Uplift | +$5.4M |
| Pro Forma EBITDA | $17.2M |
| Current Margin | 15.9% |
| Pro Forma Margin | 23.3% |
| WC Released (1x) | $2.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $18.1M | $132.3M | 7.29x | 48.8% |
| Base (11x exit) | 10.0x | 11.0x | $18.1M | $151.4M | 8.35x | 52.9% |
| Bull Case | 9.0x | 11.0x | $16.3M | $175.2M | 10.73x | 60.8% |
| Bull (12x exit) | 9.0x | 12.0x | $16.3M | $196.0M | 12.01x | 64.4% |
| Bear Case | 11.0x | 10.0x | $20.0M | $99.1M | 4.97x | 37.8% |
| Bear (11x exit) | 11.0x | 11.0x | $20.0M | $115.5M | 5.79x | 42.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 41 hospitals with 20-80 beds
- Same-state prioritization (n=42)
- Comp margins: P25=-12.9% / P50=4.0% / P75=13.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.